AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31

Authors: Caro, JJ O'Brien, JA Migliaccio-Walle, K Raggio, G
Citation: Jj. Caro et al., Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy, PHARMACOECO, 19(1), 2001, pp. 95-104

Authors: O'Brien, JA Caro, JJ
Citation: Ja. O'Brien et Jj. Caro, Alzheimer's disease and other dementia in nursing homes: Levels of management and cost, INT PSYCHOG, 13(3), 2001, pp. 347-358

Authors: Caro, JJ Payne, K
Citation: Jj. Caro et K. Payne, The value of industry-sponsored studies of initial antihypertensive therapies, CAN MED A J, 164(13), 2001, pp. 1832-1832

Authors: Caro, G Getsios, D Caro, JJ Raggio, G Burrows, M Black, L
Citation: G. Caro et al., Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis, CEPHALALGIA, 21(1), 2001, pp. 12-19

Authors: Caro, JJ Salas, M Ward, A
Citation: Jj. Caro et al., Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: Evidence from randomized clinical trials, CLIN THER, 23(7), 2001, pp. 998-1017

Authors: Caro, JJ Huybrechts, KF Kelley, HE
Citation: Jj. Caro et al., Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction, STROKE, 32(1), 2001, pp. 100-106

Authors: Caro, JJ Getsios, D Migliaccio-Walle, K Raggio, G Ward, A
Citation: Jj. Caro et al., Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care, NEUROLOGY, 57(6), 2001, pp. 964-971

Authors: Getsios, D Caro, JJ Caro, G Ishak, K
Citation: D. Getsios et al., Assessment of health economics in Alzheimer's disease (AHEAD) - Galantamine treatment in Canada, NEUROLOGY, 57(6), 2001, pp. 972-978

Authors: Caro, JJ Getsios, D Raggio, G Caro, G Black, L
Citation: Jj. Caro et al., Treatment of migraine in Canada with naratriptan: A cost-effectiveness analysis, HEADACHE, 41(5), 2001, pp. 456-464

Authors: Caro, JJ Salas, M Ward, A Goss, G
Citation: Jj. Caro et al., Anemia as an independent prognostic factor for survival in patients with cancer - A systematic, quantitative review, CANCER, 91(12), 2001, pp. 2214-2221

Authors: Desyatnikova, S Caro, JJ Andersen, PE Cohen, JI Wax, MK
Citation: S. Desyatnikova et al., Tracheoesophageal puncture in the office setting with local anesthesia, ANN OTOL RH, 110(7), 2001, pp. 613-616

Authors: Garfield, FB Caro, JJ
Citation: Fb. Garfield et Jj. Caro, Achieving patient buy-in and long term compliance with antihypertensive treatment, DIS MANAG H, 7(1), 2000, pp. 13-20

Authors: O'Brien, JA Shomphe, LA Caro, JJ
Citation: Ja. O'Brien et al., Behavioral and psychological symptoms in dementia in nursing home residents: The economic implications, INT PSYCHOG, 12, 2000, pp. 51-57

Authors: Caro, JJ Flegel, KM Orejuela, ME Kelley, HE Speckman, JL Migliaccio-Walle, K
Citation: Jj. Caro et al., Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice (vol 161, pg 493, 1999), CAN MED A J, 162(7), 2000, pp. 973-973

Authors: Caro, JJ
Citation: Jj. Caro, Disease-simulation models and health care decisions, CAN MED A J, 162(7), 2000, pp. 1001-1002

Authors: Caro, JJ Payne, K
Citation: Jj. Caro et K. Payne, Real-world effectiveness of antihypertensive drugs, CAN MED A J, 162(2), 2000, pp. 190-190

Authors: Caro, JJ
Citation: Jj. Caro, Introduction: Practice guidelines - Helpful aids or paradigm shift?, INT J TE A, 16(4), 2000, pp. 957-958

Authors: Salas, M Bubolz, T Caro, JJ
Citation: M. Salas et al., Impact of physical functioning of health status on hospitalizations, physician visits, and costs in diabetic patients, ARCH MED R, 31(2), 2000, pp. 223-227

Authors: Willey, C Redding, C Stafford, J Garfield, F Geletko, S Flanigan, T Melbourne, K Mitty, J Caro, JJ
Citation: C. Willey et al., Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure, CLIN THER, 22(7), 2000, pp. 858-871

Authors: Caro, JJ Klittich, WS Raggio, G Kavanagh, PL O'Brien, JA Shomphe, LA Flegel, KM Copley-Merriman, C Sigler, C
Citation: Jj. Caro et al., Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes, CLIN THER, 22(1), 2000, pp. 116-127

Authors: Caro, JJ Huybrechts, KF Duchesne, I
Citation: Jj. Caro et al., Management patterns and costs of acute ischemic stroke - An international study, STROKE, 31(3), 2000, pp. 582-590

Authors: Caro, JJ Caro, G Getsios, D Raggio, G Burrows, M Black, L
Citation: Jj. Caro et al., The migraine ACE model: evaluating the impact on time lost and medical resource use, HEADACHE, 40(4), 2000, pp. 282-291

Authors: Caro, JJ Klittich, WS Strauss, G
Citation: Jj. Caro et al., Could chest X-ray screening for lung cancer be cost-effective?, CANCER, 89(11), 2000, pp. 2502-2505

Authors: Caro, JJ Huybrechts, KF De Backer, G De Bacquer, D Closon, MC
Citation: Jj. Caro et al., Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium, ACT CARDIOL, 55(4), 2000, pp. 239-246

Authors: Caro, JJ Flegel, KM Orejuela, ME Kelley, HE Speckman, JL Migliaccio-Walle, K
Citation: Jj. Caro et al., Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice, CAN MED A J, 161(5), 1999, pp. 493-497
Risultati: 1-25 | 26-31